IL-1RI gene silencing by siRNA in naive CD4+CD45RA+ cells leads to a significant inhibition of IL-1RI protein expression, as well as IRF4 and RORc, in both HCs and RR MS patients in a Th17-polarizing condition. This evidence concerns the gene IRF4 and myeloid sarcoma.